Cipla Limited: timeline
Every dated event on file, newest first: history, results, dividends, splits, index changes, insider trades, layoffs and recalls, each with its source.
How the share price moved around events
An ordinary two days move it 1.12% (the median, up or down, over every day on file).
| Kind of event | Events | Typical move, 2 days | Against an ordinary 2 days | Price rose | Average, 2 days | Average, 5 days |
|---|---|---|---|---|---|---|
| Product recalls | 14 | ±1.15% | 1.0× | 57% | +0.37% | +0.22% |
From the close before each event to the close one trading day after it (2 days) and four days after it (5 days), from the exchange's daily prices (National Stock Exchange of India). A kind of event is summed up from 3 events. Moves around events say what happened, not why.
24 events
On the daily share price of CIPLA.NS on NSE (INR), as the exchange published it, not adjusted for splits or bonus issues; source: National Stock Exchange of India.
Point at a marker under the line to see the event. Green: good news by its nature (a raise, an index entry), orange: bad (a cut, a layoff), grey: neither.
2026
- Sep 18, 2026Recall: Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only2 days +0.7%5 days +1.6%
N/A
Product recalls · source: Drugs (FDA)
- Jun 29, 2026Recall: Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;2 days +1.8%5 days +1.3%
31,824 bottles
Product recalls · source: Drugs (FDA)
- Mar 20262 recalls reported to Drugs (FDA)
Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-fill; Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bott
Product recalls · source: Drugs (FDA)
- Mar 8, 2026Entered the world's top 500 companies by market cap2 days +0.9%5 days -0.5%
Ranked #452 with $11.8 billion on 8 March 2026, up from #1,386 on 5 January 2024.
Company history · source: Market-cap rankings
- Feb 18, 2026Recall: Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Ma2 days -1.1%5 days -1.3%
271 cartons - Ex: 84 outer cartons x 4 inner cartons x 4 blisters x 7 capsules
Product recalls · source: Drugs (FDA)
- Jan 2, 2026Recall: Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactur2 days +1.3%5 days -2.7%
15,221 syringes
Product recalls · source: Drugs (FDA)
2025
- Dec 22, 2025Recall: Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Stre2 days -1.1%5 days -1.5%
92,376 tubes
Product recalls · source: Drugs (FDA)
- Nov 14, 2025Recall: Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independe2 days +0.6%5 days +0.2%
12,576 bottles
Product recalls · source: Drugs (FDA)
- Oct 20252 recalls reported to Drugs (FDA)
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles ; Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Singl
Product recalls · source: Drugs (FDA)
- Jul 24, 2025Recall: Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, I2 days +4.0%5 days +5.8%
20352 packs (1x 200 MD)
Product recalls · source: Drugs (FDA)
- Jun 30, 2025Recall: Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by2 days +0.9%5 days +0.7%
13,680 ampoules
Product recalls · source: Drugs (FDA)
2024
- Oct 23, 2024Recall: Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98 (a2 days -1.2%5 days -2.2%
1,875 boxes (cipla and exlan)
Product recalls · source: Drugs (FDA)
- Mar 26, 2024Recall: Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton 2 days -1.2%5 days +0.6%
59244/3ml FFS packs
Product recalls · source: Drugs (FDA)
2023
- Jun 27, 2023Recall: Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx o2 days -1.2%5 days -1.0%
278,538 canisters
Product recalls · source: Drugs (FDA)
2022
- Dec 25, 2022Market cap passed $10 billion2 days -2.1%5 days -3.9%
$10.7 billion on 25 December 2022, from $9.9 billion on 7 January 2022.
Company history · source: Market-cap rankings
- Sep 20222 recalls reported to Drugs (FDA)
Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation ; Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL
Product recalls · source: Drugs (FDA)
- Aug 20222 recalls reported to Drugs (FDA)
Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use ; Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX on
Product recalls · source: Drugs (FDA)
- Jul 14, 2022Recall: Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limite2 days +1.3%5 days +3.0%
8,136 bottles
Product recalls · source: Drugs (FDA)
Sources: company history from Wikidata, SEC EDGAR, GLEIF and the site's own tables; product recalls from NHTSA, CPSC and FDA. Recurring events go back 15 years; the company's history is shown in full. Dividends appear when the amount per share changed; insider selling when a month's sales reach $10 million or 0.01% of the company.